Abstract:In this trial, blinded PhGA could not confirm the clinical efficacy of 1540-nm nonablative fractional laser in the treatment of hypertrophic scars, but the treatment is safe, and patients judged that the treated part had a better global appearance.
“…Efficacy of NAFL in atrophic scar, hypopigmented scar was proven in a randomized controlled trial [22]. But, NAFL treatment of hypertrophic scars did not result in greater improvement of scars than control in a randomized controlled trial [23].…”
In our study cohort, four treatments were required to reduce the VSS of thyroidectomy scars by 50% when using a combination treatment of CBL and low concentration TA ILI. Also, scar location and patient BMI are factors that affect treatment outcome.
“…Efficacy of NAFL in atrophic scar, hypopigmented scar was proven in a randomized controlled trial [22]. But, NAFL treatment of hypertrophic scars did not result in greater improvement of scars than control in a randomized controlled trial [23].…”
In our study cohort, four treatments were required to reduce the VSS of thyroidectomy scars by 50% when using a combination treatment of CBL and low concentration TA ILI. Also, scar location and patient BMI are factors that affect treatment outcome.
“…This not only induces healthy collagen turnover and remodeling, but also allows for a significant reservoir of intact dermis and epidermis to improve postprocedure healing. In this manner, both AFR and NAFR have been used to treat scars effectively [9][10][11][12][13][14].…”
Recent studies have shown great functional improvement in scar contractures with ablative fractional laser treatments; however, these treatments are accompanied by significant downtime along with risk of further scarring and infection. NAFR is an accessible treatment with a low side effect profile and to our knowledge has not been reported as efficacious in the treatment of scar contracture. This case report is novel in its demonstration of the utility of a dual wavelength NAFR in the treatment of scar contracture and functional impairment.
“…Ablative fractional erbium‐doped YAG laser therapy has been shown to be efficacious and safe in treating scars and photodamage, but it has not be studied for safety during pregnancy . Nonablative fractional laser resurfacing has not been studied during pregnancy . Intense pulsed light (IPL) and fractional photothermolysis have good safety profiles, although their use during pregnancy has not been extensively studied …”
Section: Injectablesmentioning
confidence: 99%
“…71,72 Nonablative fractional laser resurfacing has not been studied during pregnancy. 73 Intense pulsed light (IPL) and fractional photothermolysis have good safety profiles, although their use during pregnancy has not been extensively studied. 74 Most of the lasers mentioned have not been studied for safety during pregnancy, but safety has frequently been evaluated in nonpregnant patients.…”
Section: Other Lasers and Light Treatmentsmentioning
There is a lack of controlled trials addressing the safety of cosmetic procedures during pregnancy and postpartum periods. It is advisable to delay elective cosmetic procedures until after the baby is born.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.